Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Cassity

Dentist, Periodontics Ogden, UT Doctor of Dentistry

NPI 1811024011 CMS profile 1098054

5331 S Adams Ave, Ste A, Ogden, UT 84405

Open in the dashboard

General payments

$66,499

72 records reported · program years 2019–2025

Research payments

$3,485

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Cassity of Ogden, UT is reported in the CMS Open Payments database as having received $66,499 across 72 general payments and $3,485 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,837 2
2024 General $28,644 9
2024 Research $3,485 1
2023 General $697 11
2022 General $2,839 13
2021 General $15,607 12
2020 General $4,958 9
2019 General $2,917 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Cassity
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Daniel Cassity were reported at $10,837. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Daniel Cassity Dentist, Periodontics median Middle half National median
2019 $2,917 $129 $42–$367 $163
2020 $4,958 $90 $35–$265 $114
2021 $15,607 $125 $42–$411 $132
2022 $2,839 $123 $43–$364 $149
2023 $697 $125 $45–$358 $160
2024 $28,644 $119 $42–$350 $164
2025 $10,837 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Envista Holdings Corporation $39,345 8 payments
  2. Nobel Biocare USA $18,899 36 payments
  3. Straumann USA LLC $8,072 23 payments
  4. Zest Holdings, LLC $107 1 payment
  5. Kerr Corporation $39 1 payment
  6. Dentsply Sirona Inc $24 2 payments
  7. ACE Surgical Supply Co., Inc. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $31,928 6 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $13,500 3 payments
  3. Travel and Lodging $7,940 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,541 6 payments
  5. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $2,400 1 payment
  6. Food and Beverage $2,083 47 payments
  7. Education $945 3 payments
  8. Gift $162 2 payments
Products named General payments · program years 2019–2025
  1. EDUCATION $39,302 7 payments
  2. NOBELACTIVE Dental implant $14,661 20 payments
  3. NOBELACTIVE Dental implant $3,934 13 payments
  4. NOBELPARALLEL $3,934 13 payments
  5. NOBELPROCERA $2,456 3 payments
  6. NOBELSPEEDY $2,456 3 payments
  7. NOBELREPLACE $2,456 3 payments
  8. SPARK $43 1 payment
  9. KAVO MASTERMATIC $39 1 payment
  10. Implant Dentistry $24 2 payments
  11. Other $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Envista Holdings Corporation $3,485 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

774

Median for Dentist: 47

Drug cost

$4,472

Median for Dentist: $159

Branded share of claims

39.5%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 310 $1,263
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 244 $1,024
Cephalexin Generic 86 $849
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 62 $713
Metronidazole Generic 52 $591
Prednisone Generic 20 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

73 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Periodontics in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record